RecruitingPhase 3NCT04047628
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Milwaukee, WI · +22 more sites
Multiple Sclerosis clinical trials in Milwaukee, WI
12 recruiting multiple sclerosis studies with a site in Milwaukee, WI.
RecruitingPhase 3NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Sponsor: Zenas BioPharma (USA), LLC
Milwaukee, WI · +18 more sites
RecruitingPhase 3NCT07325292
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Sponsor: Sanofi
Milwaukee, WI · +33 more sites
RecruitingPhase not listedNCT06433752
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Sponsor: TG Therapeutics, Inc.
Greenfield, WI · Milwaukee, WI · Neenah, WI · +106 more sites
RecruitingPhase 3NCT05877963
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Sponsor: TG Therapeutics, Inc.
Milwaukee, WI · +40 more sites
RecruitingPhase 3NCT06408259
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Sponsor: Bristol-Myers Squibb
Milwaukee, WI · +11 more sites
RecruitingPhase 1NCT06680037
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Sponsor: TG Therapeutics, Inc.
Milwaukee, WI · +7 more sites
RecruitingNot applicableNCT06796504
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
Sponsor: SetPoint Medical Corporation
Milwaukee, WI · +8 more sites
RecruitingPhase 3NCT06846281
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Sponsor: Novartis Pharmaceuticals
Greenfield, WI · Milwaukee, WI · +42 more sites
RecruitingPhase 1NCT07224373
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Sponsor: AstraZeneca
Milwaukee, WI · +8 more sites
RecruitingPhase 1 / Phase 2NCT06063850
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
Sponsor: UniQure Biopharma B.V.
Milwaukee, WI · +17 more sites
RecruitingNot applicableNCT05735691
High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
Sponsor: Marquette University
Milwaukee, WI · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.